NZF | PMM | NZF / PMM | |
Gain YTD | 2.582 | 3.339 | 77% |
Net Assets | 2.4B | 275M | 874% |
Total Expense Ratio | 1.60 | N/A | - |
Turnover | 16.00 | 20.00 | 80% |
Yield | 5.58 | 3.78 | 148% |
Fund Existence | 24 years | 36 years | - |
NZF | PMM | |
---|---|---|
RSI ODDS (%) | 2 days ago50% | 2 days ago89% |
Stochastic ODDS (%) | 2 days ago66% | 2 days ago78% |
Momentum ODDS (%) | 2 days ago72% | 2 days ago90% |
MACD ODDS (%) | 2 days ago73% | 2 days ago82% |
TrendWeek ODDS (%) | 2 days ago75% | 2 days ago81% |
TrendMonth ODDS (%) | 2 days ago74% | 2 days ago82% |
Advances ODDS (%) | 3 days ago76% | 4 days ago82% |
Declines ODDS (%) | 19 days ago79% | 19 days ago80% |
BollingerBands ODDS (%) | 2 days ago65% | 2 days ago78% |
Aroon ODDS (%) | 2 days ago74% | N/A |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TRFM | 43.40 | 0.60 | +1.41% |
AAM Transformers ETF | |||
USSE | 32.36 | 0.42 | +1.31% |
Segall Bryant & Hamill Select Equity ETF | |||
ETW | 8.70 | 0.05 | +0.58% |
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund | |||
CNCR | 9.02 | N/A | N/A |
Range Cancer Therapeutics ETF | |||
LIAK | 194.65 | N/A | N/A |
LifeX 2054 Infl-Prt Longevity Inc ETF |